Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 597 clinical trials
PET/MRI Study on Changes of Fat and Muscle Metabolism.

presentstudies based on PET/CT have shown that elimination of the above factors, brown fat(even muscle) will still appear false positive metabolism in tumor patients. In view of the basis of Positron emission

Accepts healthy volunteers
  • 0 views
  • 03 Mar, 2022
  • 1 location
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

tumor cells may develop abnormalities 4-6 months earlier than conventional imaging examination, as long as circulating tumor cells of patients are abnormal, timely PET-CT examination will neither miss

hormone therapy
luminal
estrogen
growth factor
epidermal growth factor
  • 3 views
  • 15 May, 2022
  • 2 locations
The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

. Therefore, the importance of predicting patients with pathological complete response has increased. It has been reported that data obtained from PET-CT scans and clinical information such as tumor

  • 0 views
  • 04 Oct, 2022
  • 1 location
Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease (MITNEC C6)

. Repeat MR and PET/CT imaging and neuropsychological testing will be conducted at 24 months. The follow up assessments can also be completed at either year 1 or year 3 or Year 4 depending on the

alzheimer's disease
amyloidosis
florbetapir
dementia
positron emission tomography
  • 98 views
  • 12 May, 2022
  • 7 locations
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Quantitative parameters obtained with dynamic whole body imaging using positron emission tomography (PET) can provide additional and complementary information to standard PET. Dynamic imaging allows for better understanding of the behavior of the radio-pharmaceutical because it can be followed over time. Thought to be difficult to perform with currently available …

68ga-dotatoc
pet/ct scan
dotatoc
ct scan
fdg pet/ct
  • 3 views
  • 24 Feb, 2022
  • 1 location
Prospective, Observational, Multi-centred, Non-interventional Research Project on Plasma Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Tumor Management

The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify …

  • 0 views
  • 18 Oct, 2022
  • 1 location
Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Longitudinal imaging in patients with large vessel vasculitis to predict further disease course

vasculitis
positron emission tomography/computed tomography
  • 0 views
  • 15 Oct, 2022
  • 1 location
Biological Interconnection of Brain Neurobiological Activity With Atherosclerotic Plaque Vulnerability and the Prognostic Value (Blueprint)

The effect of brain-heart interaction remains unclear. The study aims to investigate the biological interconnection between brain neural activity and coronary plaque morphological and inflammatory features, as well as their connection with clinical outcomes.

  • 0 views
  • 13 Oct, 2022
  • 3 locations
SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY (NEOSENTITURK)

Omitting axilary lymph node dissection (ALND) following SLNB with residual cancer in patients with locally advanced disease after neoadjuvan chemotherapy (NAC) is still controversial. In this study, the investigators evaluated factors affecting local recurrence and outcome in patients with locally advanced breast cancer (LABC), who underwent sentinel lymph node (SLN) …

Accepts healthy volunteers
  • 0 views
  • 25 Feb, 2022
  • 1 location
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Molecular analysis identifies residual disease by overcoming the sensitivity of imaging methods and therefore has the potential for integrating with therapy provided by FDG-PET alone. It is a well known fact that tumor DNA circulating in plasma (ctDNA) reflects the mutational profile of tumor cells and can be used to …

lymphoma
  • 0 views
  • 10 Mar, 2022
  • 1 location